Medline’s IPO underscores broad investor appetite for a sleepy corner of the healthcare business
Summarize this article with:
Medline’s IPO underscores broad investor appetite for a sleepy corner of the healthcare businessForget weight-loss drugs and the latest development for their makers — the hottest healthcare stock right now makes those ubiquitous striped blankets for newborns, and more than 300,000 other medical and surgical products.Medline’s stock MDLN soared more than 40% above its IPO price on Wednesday, its first day of trading. That underscores broad investor interest in an important, though not splashy, corner of the healthcare business.About the AuthorClaudia Assis is a San Francisco-based reporter for MarketWatch. Follow her on Twitter @ClaudiaAssisMW.Jaimy Lee is a healthcare reporter and editor for MarketWatch. She is based in New York.Copyright © 2025 MarketWatch, Inc. All rights reserved.